nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSK—gall bladder—gallbladder cancer	0.0976	0.129	CbGeAlD
Boceprevir—CTSS—gall bladder—gallbladder cancer	0.0855	0.113	CbGeAlD
Boceprevir—CTSV—pancreas—gallbladder cancer	0.073	0.0964	CbGeAlD
Boceprevir—CTSL—epithelium—gallbladder cancer	0.067	0.0884	CbGeAlD
Boceprevir—CTSL—pancreas—gallbladder cancer	0.0597	0.0788	CbGeAlD
Boceprevir—CTSK—pancreas—gallbladder cancer	0.045	0.0593	CbGeAlD
Boceprevir—CMA1—liver—gallbladder cancer	0.0444	0.0586	CbGeAlD
Boceprevir—CTSS—pancreas—gallbladder cancer	0.0394	0.052	CbGeAlD
Boceprevir—CTSL—liver—gallbladder cancer	0.038	0.0501	CbGeAlD
Boceprevir—CMA1—lymph node—gallbladder cancer	0.034	0.0449	CbGeAlD
Boceprevir—CTSL—lymph node—gallbladder cancer	0.0291	0.0384	CbGeAlD
Boceprevir—CTSK—liver—gallbladder cancer	0.0286	0.0378	CbGeAlD
Boceprevir—CTSS—liver—gallbladder cancer	0.0251	0.0331	CbGeAlD
Boceprevir—CTSK—lymph node—gallbladder cancer	0.0219	0.0289	CbGeAlD
Boceprevir—CTSS—lymph node—gallbladder cancer	0.0192	0.0254	CbGeAlD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—KEAP1—gallbladder cancer	0.0136	0.056	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—KEAP1—gallbladder cancer	0.0136	0.056	CbGpPWpGaD
Boceprevir—CYP3A5—pancreas—gallbladder cancer	0.0131	0.0173	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB4—gallbladder cancer	0.00954	0.0393	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—KEAP1—gallbladder cancer	0.00926	0.0382	CbGpPWpGaD
Boceprevir—CYP3A5—liver—gallbladder cancer	0.00832	0.011	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB3—gallbladder cancer	0.00825	0.034	CbGpPWpGaD
Boceprevir—ABCB1—epithelium—gallbladder cancer	0.0078	0.0103	CbGeAlD
Boceprevir—ABCB1—pancreas—gallbladder cancer	0.00695	0.00917	CbGeAlD
Boceprevir—CTSV—Adaptive Immune System—KEAP1—gallbladder cancer	0.00672	0.0277	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KEAP1—gallbladder cancer	0.00672	0.0277	CbGpPWpGaD
Boceprevir—CYP3A4—liver—gallbladder cancer	0.00625	0.00824	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—KEAP1—gallbladder cancer	0.00557	0.023	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.00517	0.0213	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KEAP1—gallbladder cancer	0.00458	0.0189	CbGpPWpGaD
Boceprevir—ABCB1—liver—gallbladder cancer	0.00442	0.00584	CbGeAlD
Boceprevir—CTSV—Immune System—KEAP1—gallbladder cancer	0.00407	0.0168	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KEAP1—gallbladder cancer	0.00407	0.0168	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.00393	0.0162	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.00358	0.0148	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—gallbladder cancer	0.00339	0.00447	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.00339	0.014	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KEAP1—gallbladder cancer	0.00338	0.0139	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB4—gallbladder cancer	0.00332	0.0137	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB4—gallbladder cancer	0.00332	0.0137	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB4—gallbladder cancer	0.00319	0.0132	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB4—gallbladder cancer	0.00319	0.0132	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.00288	0.0119	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB3—gallbladder cancer	0.00287	0.0119	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB3—gallbladder cancer	0.00287	0.0119	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KEAP1—gallbladder cancer	0.00278	0.0115	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB3—gallbladder cancer	0.00276	0.0114	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB3—gallbladder cancer	0.00276	0.0114	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB4—gallbladder cancer	0.00275	0.0114	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERBB4—gallbladder cancer	0.00264	0.0109	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB3—gallbladder cancer	0.00238	0.00982	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERBB3—gallbladder cancer	0.00229	0.00943	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB4—gallbladder cancer	0.00227	0.00936	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERBB4—gallbladder cancer	0.00218	0.00898	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB3—gallbladder cancer	0.00196	0.00809	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB4—gallbladder cancer	0.00194	0.00799	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB4—gallbladder cancer	0.00194	0.00799	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERBB3—gallbladder cancer	0.00188	0.00777	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—BCL2—gallbladder cancer	0.00185	0.00765	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—BCL2—gallbladder cancer	0.00185	0.00765	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB2—gallbladder cancer	0.0018	0.00743	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB2—gallbladder cancer	0.0018	0.00743	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB2—gallbladder cancer	0.00173	0.00714	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB2—gallbladder cancer	0.00173	0.00714	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB3—gallbladder cancer	0.00167	0.0069	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB3—gallbladder cancer	0.00167	0.0069	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB4—gallbladder cancer	0.0016	0.00662	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—BCL2—gallbladder cancer	0.00154	0.00634	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB2—gallbladder cancer	0.00149	0.00616	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERBB2—gallbladder cancer	0.00143	0.00591	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB3—gallbladder cancer	0.00139	0.00572	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—gallbladder cancer	0.00137	0.00565	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NRAS—gallbladder cancer	0.00137	0.00565	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB4—gallbladder cancer	0.00132	0.00545	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—gallbladder cancer	0.00132	0.00543	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NRAS—gallbladder cancer	0.00132	0.00543	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—BCL2—gallbladder cancer	0.00127	0.00522	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—gallbladder cancer	0.00125	0.00515	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—gallbladder cancer	0.00125	0.00515	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB2—gallbladder cancer	0.00123	0.00507	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—gallbladder cancer	0.0012	0.00495	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—gallbladder cancer	0.0012	0.00495	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERBB2—gallbladder cancer	0.00118	0.00487	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—gallbladder cancer	0.00118	0.00487	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KRAS—gallbladder cancer	0.00118	0.00487	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB4—gallbladder cancer	0.00116	0.0048	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB3—gallbladder cancer	0.00114	0.00471	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NRAS—gallbladder cancer	0.00114	0.00469	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—gallbladder cancer	0.00113	0.00467	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—gallbladder cancer	0.00113	0.00467	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NRAS—gallbladder cancer	0.00109	0.0045	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2—gallbladder cancer	0.00108	0.00446	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2—gallbladder cancer	0.00108	0.00446	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—gallbladder cancer	0.00105	0.00433	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—gallbladder cancer	0.00105	0.00433	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—gallbladder cancer	0.00103	0.00427	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB3—gallbladder cancer	0.00101	0.00415	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—gallbladder cancer	0.001	0.00414	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—gallbladder cancer	0.001	0.00414	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—gallbladder cancer	0.000993	0.0041	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KRAS—gallbladder cancer	0.000977	0.00403	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—gallbladder cancer	0.000963	0.00397	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—gallbladder cancer	0.000963	0.00397	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KRAS—gallbladder cancer	0.000939	0.00387	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—gallbladder cancer	0.000935	0.00386	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—gallbladder cancer	0.000898	0.0037	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—gallbladder cancer	0.000895	0.00369	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—gallbladder cancer	0.000869	0.00359	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—gallbladder cancer	0.000852	0.00352	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—gallbladder cancer	0.000831	0.00343	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—gallbladder cancer	0.000818	0.00338	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—gallbladder cancer	0.000805	0.00332	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—gallbladder cancer	0.000798	0.00329	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—gallbladder cancer	0.000798	0.00329	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—gallbladder cancer	0.000798	0.00329	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—gallbladder cancer	0.000773	0.00319	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—gallbladder cancer	0.000737	0.00304	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—gallbladder cancer	0.000727	0.003	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—gallbladder cancer	0.000727	0.003	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—gallbladder cancer	0.000716	0.00295	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—gallbladder cancer	0.000687	0.00283	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—gallbladder cancer	0.000687	0.00283	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—gallbladder cancer	0.000684	0.00282	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—gallbladder cancer	0.000661	0.00273	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—gallbladder cancer	0.000657	0.00271	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—gallbladder cancer	0.000631	0.0026	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—gallbladder cancer	0.000603	0.00249	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—gallbladder cancer	0.000584	0.00241	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—gallbladder cancer	0.000584	0.00241	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—gallbladder cancer	0.000569	0.00235	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—gallbladder cancer	0.000545	0.00225	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000505	0.00208	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—gallbladder cancer	0.000496	0.00205	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000491	0.00202	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—gallbladder cancer	0.000484	0.002	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—gallbladder cancer	0.00048	0.00198	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—gallbladder cancer	0.000469	0.00193	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—gallbladder cancer	0.000437	0.0018	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—gallbladder cancer	0.000413	0.0017	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—gallbladder cancer	0.000398	0.00164	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—gallbladder cancer	0.000367	0.00151	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—gallbladder cancer	0.000351	0.00145	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00034	0.0014	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000321	0.00133	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000286	0.00118	CbGpPWpGaD
